EKF Diagnostics
Avon House, 19 Stanwell Road, Penarth, Cardiff, CF64 2EZ, United Kingdom
Overview
EKF Diagnostics is a worldwide manufacturer of point of care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1C).
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 9
Sector focus
- Health Care
- Health Diagnostics
- Manufacturing
Investment portfolio
- Trellus Health
Led · Seed · Aug 2020
Trellus Health provides a multidisciplinary connected care platform that coordinates clinical and behavioral health to support whole-person care for chronic conditions, initially focused on IBD including Crohn’s disease and ulcerative colitis. The company leverages a patent-pending GRITT-IBDTM resilience assessment and a personalized treatment methodology developed at Mount Sinai to support patient resilience and wellness. Trellus aims to improve outcomes and reduce healthcare costs for patients, employers, and the healthcare system through its connected care approach. The company was co-founded by Marla Dubinsky, MD, and Laurie Keefer, PhD, and is led by CEO Monique Fayad. Financially, Trellus announced a $5M seed funding round to support commercialization and growth efforts. It has entered an exclusive multi-year contract with Mount Sinai Health System to commercialize its GRITT-IBDTM methodology.